John A. St. Cyr, M.D., Ph.D., FAHA: Expert, Author, Writer and Cardiovascular Medical Devices Inventor

John A. St. Cyr, M.D., Ph.D: Expert, Author, Writer (EAW) and Cardiovascular Medical Devices Inventor (CVD – MDI)

Roles at http://pharmaceuticalintelligence.com

EAW – Cardiovascular research
Category OWNER – Myocardial metabolism, Myocardial ischemia, Myocardial adenine nucleotide metabolism
Category OWNER – Aortic and mitral valve surgeries
Category OWNER – Cardiomyopathy
EAW & CVD – MDI: Medical devices: R & D
Category OWNER: Pre-clinical animal model development
Category OWNER: Congenital heart disease
EAW – Stem cells for regenerative medicine

John A. St.Cyr, M.D., Ph.D.

OFFICE: Jacqmar, Inc.

10965 53^rd Avenue North

Plymouth, MN 55442

Phone: (763) 473-3007

Fax: (763) 383-5155

Email: LMS94@aol.com

Congenital@aol.com

EDUCATION:

Washburn High School, Minneapolis, MN, (National Honor Society), 1967

University of Minnesota, B.A., (Phsl, Summa Cum Laude), 1973

University of Minnesota, B.S., (Medicine), 1975

University of Minnesota, M.S., (Phsl-major, Biochem-minor), 1977

University of Minnesota, M.D., 1980

Certificate, Research Associate, Cardiovascular-Thoracic pathology,

J. E.Edwards Registry of Cardiovascular Diseases (Drs. Edwards and Titus), 1988

Certificate, Chief Surgical Resident (1987-1988), Completion of General Surgical Residency,

1988, University of Minnesota (1980-1988)

University of Minnesota, Ph.D., (Surgery-major, Phsl-minor), 1988

Cardiovascular-Thoracic Surgical Residency, University of Colorado

Health Sciences Center, 1988-1991

Certificate, Chief Cardiovascular Surgical Resident, 1990-91;

Pediatric Cardiovascular-Thoracic Surgical/Transplantation Clinical Fellow,

Department of Cardiovascular-Thoracic Surgery, University of Minnesota, 1991-92

THESES:

Master of Science, “Measurable effects of hypoxia on the microvascular permeability in the isolated adult rabbit lung”

Doctor of Philosophy, “Ribose enhanced recovery of myocardial ATP levels”

HONORS/AWARDS:

Summa Cum Laude (B.A., Physiology), University of Minnesota

Minnesota Surgical Society Research-Essay Award

Drs. R.L. Varco & J.E. Foker, Cardiovascular Scholarship

MERCK Award

Medical Student Research Award, Minnesota Medical Foundation, University of Minnesota

Phi Kappa Phi Honorary Society

Individual National Institute of Health Research Service/Fellowship Award

Minnesota Heart Association, Grant-in-Aid Research Award

Vikings Children’s Fund, Grant-in-Aid Research Award, Co-investigator

Physician’s Recognition Award, American Medical Association

Minnesota Heart Association, Grant-in-Aid Research Award

Physician’s Recognition Award, American Medical Association

American College of Cardiology, Bristol Laboratories Affiliate Travel Award

Marquis Who’s Who: West, Science and Engineering, America, World, Midwest, Medicine & Healthcare

Who’s Who in American Inventors

International Who’s Who of Professionals

American Directory of Who’s Who in Executives and Businesses

Medtronic Inc., Technical Contributor of the Year Award (Aortic valve implant model)

America’s Registry of Outstanding Professionals

2000 Outstanding Scientists of the 21^st Century (1^st Edition)

Strathmore’s Who’s Who

Fellow, American Heart Association, Cardiovascular-Thoracic Surgical Division, FAHA

Fellow, International Biographical Association, FIBA

2000 Eminent Scientists of Today, International Biographical Association

Medtronic, Inc., Honorary Research Award (PRL), Advancing Medical Technology

Madison Who’s Who

Premier International Who’s Who of Outstanding Executives/Professionals, Honorary member

FELLOWSHIPS AND GRANTS:

Individual National Institute of Health Research Service/Fellowship Award

(“Adenosine Metabolism in Cardiovascular Surgery”)

Minnesota Heart Association, Grant-in-Aid Research Award

(“Adenosine Metabolism in Cardiovascular Surgery”)

Vikings Children’s Fund, Grant-in-Aid Research Award (“Prediction of Liver Function using Adenine Nucleotide Measurements after Warm Ischemia and Cold Storage”), Co-investigator

Minnesota Heart Association, Grant-in-Aid Research Award

(“Adenosine Metabolism in Cardiovascular Surgery”)

Minnesota Medical Foundation Research Grant (“High Energy Phosphate Levels in the

Hypertrophic Right Ventricle”)

Children’s Hospital, Denver, Co., Clinical Study Grant/Funding (“Ribose supplementation in

children undergoing cardiac surgery”)

Minnesota Medical Foundation Research Grant (“Energy metabolism in the

Immature myocardium”), Co-investigator

PATENTS:

Issued:

Suture removal device, USP5250052

Double layer prophylactic incorporating pharmacological fluid and spiral barrier layer, USP5623945

Compositions for increasing energy in vivo, USP6159942

Method for determining viability of a myocardial segment, USP6339716

Method for raising the hypoxic threshold, USP6218366

Use of ribose to prevent cramping and soreness in muscles, USP6159943

Compositions for increasing athletic performance in mammals, USP6429198

Dual lumen adjustable length cannulae for liquid perfusion or lavage, USP6692473

Method for treating acute mountain sickness, USP6511964

Compositions for increasing energy in vivo, USP6534480

Compositions for the storage of platelets, USP6790603

Compositions for enhancing the immune response, USP6663859

Composition methods for improving cardiovascular function, USP7553817

Rejuvenation of stored blood, USP7687468

Pending applications:

Method for improving ventilatory efficiency, SN20050277598

Storage of blood SN20070111191

Ventilatory benefits of ribose in COPD, smoking, SN

Use of ribose in recovery from anesthesia, SN20070105787

Use of ribose to alleviate rhabdomyolysis and the side effects of statin drugs, SN20060135440

Use of ribose in first response to acute myocardial infarction, SN20100055206

Compositions and methods for improving cardiovascular function, SN20100009924

Use of ribose in lessening the clinical symptoms of aberrant firing of neurons, SN20090286750

Compositions for indoor tanning, SN20090232750

Compositions for improving and repairing skin, SN20090197819

Use of ribose for recovery from anesthesia, SN20090197818

Cosmetic use of D-ribose, SN20080312169

Method for improving ventilator efficiency SN20100099630

Method and compositions for improving pulmonary hypertension, SN20080146514

Storage of blood, SN20070111191

Compositions and methods for feeding poultry, SN201100221446

Use of D-ribose for fatigued subjects, SN20100189785

Fibrin sealants and platelet concentrates applied to effect hemostasis in the interface of an implantable medical device with body tissue, SN20060190017

Compositions for reducing the deleterious effects of stress and aging, SN20120045426

Provisional patents:

Use of ribose in pre-slaughtering of animals

Rescue therapy for acute decompensated heart failure

Combination of D-ribose plus caffeine

Role of ribose in reducing joint swelling in mammals

Role of D-ribose in cardiac remodeling

Role of D-ribose in cachexia

Use of ribose in stem cells

Use of ribose in cardioplegia

Use of ribose for doping blood for cardioplegia

Surgical adhesive for bleeding situations

Metabolic approach with EECP

Role of ribose in mitral regurgitation

Compositions for the preservation of morphology in stored blood

Methods and nutritional supplements for improving the quality of meat

MEMBERSHIPS:

University of Minnesota Alumni Association

American Association for the Advancement of Science

American Medical Association

Hennepin County Medical Society

New York Academy for Sciences

Phi Kappa Phi Honorary Society

University of Minnesota Medical Alumni Society

Association for Academic Surgeons

American Physiological Society

American Heart Association, Basic Science Committee

American Heart Association, Cardiovascular Surgery

Minnesota Academy for Sciences

University of Colorado Health Sciences Alumni Association

University of Colorado Alumni Association

International Society for Heart Research

American Heart Association, Council of Cardiopulmonary & Critical Care

International Biographical Association, Fellow (FIBA)

Fellow, American Heart Association, Cardiovascular-Thoracic Surgery Committee (FAHA)

Research Council, International Biographical Association

St. Jude’s DMC (Data Management Committee)

Honorary member, Premier International Who’s Who of Outstanding Executives/Professional

Member, Board of Directors, LCTA, LLC

Scientific Advisory Board, ImmuMed, Inc.

Owen H. Wangensteen Surgical Society

C. Walton & Richard C. Lillehei Surgical Society

CURRENT POSITIONS:

Independent Medical/Surgical Consulting

Medical/Surgical Consultant, Physiological Research Laboratories, Minneapolis, MN

Vice President, Research and Development, Jacqmar, Inc., Plymouth, Minnesota

Consultant, Last Chance Tissue Adhesive, Inc., Mpls, MN

Research Council, International Biographical Association

Member, Board of Governors, Viacell, LLC, Mpls, MN

Chief Medical Advisor, RCRI, Inc.

Member, Board of Directors, LCTA, LLC

Surgical Consultant, Integra, Inc., Minneapolis, MN

Member, St. Jude’s Data Management Committee

Consultant, ImmuMed, Inc.

Surgical/Medical Consultant, NAMSA, Inc., Minneapolis, MN

EDITORIAL BOARDS

The Open Nutraceuticals Journal

The Open Cardiovascular and Thoracic Journal

Blood Flow Online

Journal of Cardiology and Therapy

PUBLICATIONS:

1. St.Cyr JA: “Measurable effects of hypoxia on the microvascular permeability in the isolated adult rabbit lung,” Master’s thesis, University of Minnesota, 1977.

2. Ward HB, Kriett J, St.Cyr JA, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Relationship between recovery of myocardial ATP levels and cardiac function following ischemia. J Am Coll Cardiol 3(2):544, 1984.

3. Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM, Foker JE: Enhanced recovery of ATP levels following global ischemia. Surg 96(2):248, 1984.

4. Foker JE, Ward HB, St.Cyr JA, Alyono D, Bianco RW, Kriett JM: Enhanced ATP retrun after global ischemia. Eur Heart J 5(suppl):91, 1984.

5. St.Cyr JA, Bianco RW, Ascher NL, Foker JE: Consequences of ischemia on organ energy metabolism. Trans Proceed 17(1):1468, 1985.

6. Schneider J, St.Cyr JA, Thompson T, Johnson D, Burke B, Foker JE: The changing spectrum of cystic pulmonary lesions requiring surgical resection in infants. J Thorac Cardiovasc Surg 89(3):332, 1985.

7. St.Cyr JA, Braunlin E, Moller J, Ring WS, Molina JE, Foker JE: Management of pulmonary atresia and intact ventricular septum. J Am Coll Cardiol 5(2): 477, 1985.

8. Fath J, St.Cyr J, Constantinides F, Alden P, Ascher N, Bianco R, Foker J, Cerra F: Alterations in amino acid clearance during ischemia predict hepatocellular ATP changes. Surg 98(3):396, 1985.

9. Einzig S, St.Cyr JA, Bianco RW, Schneider JR, Lorenz E, Foker JE: Myocardial ATP repletion with ribose infusion. Ped Res 19(4):127A, 1985.

10. Schneider JR, St.Cyr JA, Mahoney JR, Bianco RW, Ring WS, Foker JE: Recovery of ATP and return of function after global ischemia. Circ (Part II), 72(4):III_298, 1985.

11. St.Cyr JA, Shearen J, Delaney JD: New therapeutic approach for mixed anaplastic carcinoma of the thyroid. Minn Med 68(12):893, 1986.

12. St.Cyr J, Ward H, Kriett J, Alyono D, Einzig S, Bianco R, Anderson R, Foker J: Long term model for evaluation of myocardial metabolic recovery following global ischemia. In: Brautbar, N.(ed), Myocardial and Skeletal Muscle Bioenergetics, AEMB series. New York, NY, PLenum Publishing 194:401, 1986.

13. Bianco RW, St.Cyr JA, Rasmussen TM, Clack RM, Schneider JR, Shim HS, Sandstad J, Rysavy RB, Foker JE: Canine model for long term evaluation of prosthetic mitral valves. J Surg Res 41(2):134, 1986.

14. St.Cyr JA, Bianco RW, Foker JE, Noren G, Staley N, Wang TC, Einzig S: Myocardial high energy phosphate levels in cardiomyopathic turkeys. J Surg Res 41(3):256, 1986.

15. Kingsley_Hickman P, Sako EY, Andreone PG, St.Cyr JA, Michurski S, Foker JE, From AHL, Petein M, Ugurbil K: 31P NMR measurement of ATP synthesis in perfused intact rat hearts. J Fed Europ Biochem Soc 198(1):159, 1986.

16. St.Cyr JA, Ward HB, Kriett JM, Alyono D, Einzig S, Bianco RW, Anderson RW, Foker JE: Long term model for evaluation of myocardial metabolic recovery following global ischemia. Adv Exp Med Biol 194:401, 1986.

17. Einzig S, St.Cyr J, Schneider J, Bianco R, Foker J: Maintained myocardial ATP with long term ribose. Ped Res 20(4),Part II:169A, 1986.

18. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, Ugurbil K, Foker JE: Dobutamine increases efficiency of ATP utilization in the post_ischemic isolated heart. Surg Forum XXXVII:236, 1986.

19. Sako EY, Kingsley_Hickman PB, St.Cyr JA, Andreone PG, From AHL, Ugurbil K, Foker JE: Effect of ischemia and dobutamine on myocardial ATP production. Circ, Part II, 74(4):II_272, 1986.

20. St.Cyr JA, Thompson T, Johnson D, Ferrara TB, Foker JE: The diagnosis and treatment of gastroesophageal reflux in infancy. J Thorac Cardiovasc Surg 92(4):661, 1986.

21. Foker JE, Braunlin EA, St.Cyr JA, Moller JH, Ring WS, Molina JE: Management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg 92(4):706, 1986.

22. St.Cyr JA, Elick BA, Stock P, Freese D, Sharp H, Payne W, Bloomer J, Najarian J, Ascher N: Use of triple therapy and percutaneous needle biopsy to minimize rejection following liver transplantation. Trans Proceed 19(1):2451, 1987.

23. St.Cyr JA, Ward HB, Molina JE: Successful correction of a thoracic aortic aneurysm_bronchial fistula. J Card Surg 2:109, 1987.

24. St.Cyr JA, Bianco RW, Judd D, Pierpont ME, Staley N, Noren G, Foker JE, Einzig S: A new method of urine collection in turkeys and chickens. Lab Animal Sci 37:566, 1987.

25. Tveter KJ, St.Cyr JA, Bianco RW, Einzig S, Foker JE: Ribose enhanced recovery of diastolic function after global myocardial ischemia. Ped Res 23:226A, 1988.

26. St.Cyr JA: “Ribose enhanced recovery of myocardial ATP levels,”Ph.D. thesis, University of Minnesota, 1988.

27. St.Cyr JA, Lindberg E, Van Tassel R, Gannon PG: Contained rupture of an ascending aortic aneurysm with cystic medial necrosis, two years after blunt chest trauma. Contemp Surg 33(6):20, 1988.

28. St.Cyr JA, Jamieson SW: Heart lung transplantation. In: Martini N, Vogt_Moykopf I (eds): International Trends in General Thoracic Surgery. Thoracic Surgery: Frontiers and Uncommon Neoplasms. CV Mosby Co, St.Louis, Baltimore, Toronto, Vol 5:99, 1989.

29. St.Cyr JA, Schneider JR, Mahoney JR, Bianco RW, Tveter KJ, Einzig S, Foker JE: Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model. J Surg Res 45:157, 1989.

30. St.Cyr JA, Ferrara TB, Thompson T, Johnson D, Foker JE: Treatment of pulmonary manifestations of gastroesophageal reflux in children two years of age or less. Am J Surg 157:400, 1989.

31. Tveter K, St.Cyr J, Schneider J, Bianco R, Foker J: Enhanced recovery of diastolic function after global myocardial ischemia in the intact animal. J Am Coll Cardiol 13(2,A):130A, 1989.

32. Bensard DA, St.Cyr JA, Johnston MR: Acute pleuritic chest pain and lung mass in an elderly female. Chest 97(6):1473, 1990.

33. St.Cyr JA: Myocardial ischemia is irrelevant. In: Harken A (ed), Surgical Debates III, Philadelphia_Toronto, BC Decker Inc, Vol III:185, 1990.

34. Read R, St.Cyr JA, Tornabene S, Whitman GJ: Improved cannulation method for extracorporeal membrane oxygenation (ECMO). Ann Thorac Surg 50(4):670, 1990.

35. Durmowitz A, St.Cyr J, Clarke D, Stenmark K: Unilateral pulmonary hypertension as a result of chronic increased flow to one lung. Amer Rev Resp Dis 142(1):230, 1990.

36. Read R, St.Cyr J, Manek J, Whitman G, Hopeman A: Bronchial anomaly of the right upper lobe; a case report with a discussion of the literature. Ann Thorac Surg 50(6):980, 1990.

37. Fullerton DA, Kirson LE, St.Cyr J, Kennard T, Whitman GJR: Human pulmonary vascular resistance (PVR) is hydrogen ion not pCO2 sensitive. J Surg Res 49(4): 375, 1990.

38. Jones RL, St.Cyr JA, Tornabene SP, Lauber B, Harken AH: Reversible pulmonary hypertension secondary to mitral valvular disease as an indication for extracorporeal membrane oxygenation. Cardiovasc & Vasc Anesth 5(5):494, 1991.

39. Fullerton DA, St.Cyr J, Campbell DN, Clarke DR, Toews WH, See WM: The Bezold_Jarisch reflex in postoperative pediatric cardiac surgical patients. Ann Thorac Surg 52(3):534, 1991.

40. St.Cyr JA, Fullerton DA: Letter to the editor Aortic replacement with sutureless intraluminal graft. Texas Heart Instit J 18(2):144-45, 1991.

41. St.Cyr JA, Fullerton DA, Harken AH: Repair of the torn friable right atrium following decannulation. Ann Thorac Surg 52(6):1344, 1991.

42. Grosso MA, Banerjee A, St.Cyr JA, Rogers KG, Brown JM, Clarke DR, Harken AH: Cardiac 5’_nucleotidase increases with age and inversely relates to recovery from ischemia. J Thorac Cardiovasc Surg 103(2):206-209, 1992.

43. St.Cyr JA, Bolman III RM, Foker JE: Cardiac transplantation following the modified Fontan procedure. Editorial. Trans Sci 2(1):3, 1992.

44. St.Cyr JA, Campbell DN, Fullerton DA, Grosso M, Bishop DA, Clarke DR: Cryoperserved allograft repair of aortic hypoplasia-interrupted aortic arch. Ann Thorac Surg 53(6):1110, 1992.

45. St.Cyr JA, Fullerton DA: Successful repair of a pseudoaneurysm, originating from a true left ventricular aneurysm. Am Heart Jour 124(5):1381, 1992.

46. DeMarco C, Alonso K, Nardi C, Pontiggio P, Mathe G, Zablow A, St.Cyr J, Shecterle L: Hyperthermia: An effective AIDS treatment. PWA Coalition Newsline 86:17-21, 1993.

47. Irwin E, Clack R, Lang G, St.Cyr J, Runge W, Foker J, Bianco R: Long term evaluation of prosthetic mitral valves in sheep. J Invest Surg 6(2):133, 1993.

48. Fullerton DA, Kirson L, St.Cyr JA, Kinnard T, Whitman GJR: Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation. J Thorac Cardiovasc Surg 106(3):528, 1993.

49. Fullerton DA, Kirson LE, St.Cyr JA, Albert JD, Whitman GJR: The influence of respiratory acid-base status of adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 103(4):1091, 1993.

50. Esper E, Krabill KA, St.Cyr JA, Patton C, Foker JE: Repair of multiple mycotic aortic aneurysms in a young infant with reviewof the literature. J Ped Surg 28(12):1553, 1993.

51. St.Cyr JA: US Patent, “Suture Removal Device,” #5250052, 1993.

52. St.Cyr JA: Who’s Who of American Inventors, 1994-95 edition, page 142, 1994.

53. St.Cyr JA, Shecterle LM: Low flow extracorporeal hyperthrmia treatment in HIV infected patients with Kaposi’s Sarcoma, Phase I clinical protocol, copyrighted 1993, 1996.

54. Fullerton DA, St.Cyr JA, Albert JA, Grover FL: Hemodynamic advantages of left atrial epinephrine administration after cardiac operations. Ann Thorac Surg 56(6):1263, 1993.

55. Shecterle LM, St.Cyr JA: Does hyperthermia have a therapeutic role in HIV disease? J Minnesota Acad Sciences 58(2):27-30, 1994.

56. Shecterle L, St.Cyr J: Extracorporeal whole body hyperthermia as a treatment option in HIV/AIDS disease, “Low flow technique,” Feasibility clinical study, clinical instruction manual, Copyright-Organetics, Ltd., 1994.

57. St. Cyr JA, Fullerton DA, Zamora M, Hopeman AR: Tracheobranchial disruption: postoperative management with jet ventilation to minimize airway pressure. J Cardiovasc Surg 35(1):79-81, 1994.

58. Fullerton DA, St. Cyr JA, Fall SM, Whitman GJ: Protection of the patent internal mammary artery by-pass graft from subsequent sternotomy. J Cardiovasc Surg 35(6):499-501, 1994.

59. St.Cyr JA, Shecterle LM: Effects of hypoxia on pulmonary microvascular permeabilibty in the isolated adult rabbit lung. J Biomed Sci 2(1):70-76, 1995.

60. Shecterle LM, Gasper P, St.Cyr JA: Current and future prospects of whole body hyperthermia for deactivation of HIV. J AIDS Patient Care 9(2):85, 1995.

61. Shecterle LM, Kelly T, St.Cyr JA: Therapy with extracorporeal whole body hyperthermia. Abstract, Serono Symposia: Idea to product. November, 1994, Washington, D.C., Abstract booklet.

62. Shecterle LM, Kelly T, Zablow A, St.Cyr JA: Altered lipid metabolism with hyperthermia. FASEB Journal 9(4):A646, 1995.

63. Shecterle LM, Gasper PW, St.Cyr JA: Hyperthermia as a potential treatment in HIV disease. Alternative Medicine Journal 2(3):28-32, 1995.

64. Shecterle LM, St.Cyr JA: Letter to the editor, Localized or systematic in vivo heat-inactivation of human immunodeficiency virus (HIV); a mathematical analysis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(3):391, 1995.

65. Shecterle LM, St.Cyr JA: Rate of temperature rise using a hot air whole body hyperthermia device. Southern Med Journal 88(10): PS142, PS143, 1995.

66. Shecterle LM, Gasper PW, St.Cyr JA: Potential role of using whole body hyperthermia to treat Lyme disease. Southern Med Journal, 88(10): PS142, 1995.

67. Shecterle LM, Kelly T, St.Cyr JA: Canine Experimentation with low flow extracorporeal whole body hyperthermia. Southern Med Journal 88(10): PS143, 1995.

68. Shecterle LM, Gasper PW, St.Cyr JA: Could whole body hyperthermia have a role in the treatment of Lyme disease? Alternative Medicine Journal 2(4):19-20, 1995.

69. Shecterle LM, St.Cyr JA: Whole Body Hyperthermia as a Potential Therapeutic Option, Invited submission. Cancer Biotherapy 10(4):253-256, 1995.

70. Zablow A, Dorian R, Kelly T, St. Cyr JA: Feasibility trial using extracorporeal whole body hyperthermia in AIDS patients. J Investigative Medicine 44(1):192A, 1996.

71. Henry K,Erice A, Balfour H, Beatty C, St. Cyr JA: Acute effects of whole body hyperthermia on plasma HIV-RNA levels. Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, p. 26 Abstr 373, 1996.

72. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 1:261, 1996.

73. St.Cyr, JA: Medical Minute….Hyperthermia. Medcorp News 5(second quarter):2, 1996.

74. Fullerton DA, McIntyre RC, Kirson LE, St.Cyr JA, Whitman GJR, Grover FL: Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 61:696-701, 1996.

75. St.Cyr JA, Kelly T, Shecterle LM: Cranial venous effluent temperature assessment during extracorporeal whole body hyperthermia. FASEB Journal 10(3):A118, 1996.

76. Shecterle LM, Kelly T, Dorian R, St.Cyr JA: Maintenance of renal and hepatic function with dopamine during and following extracorporeal whole body hyperthermia. FASEB Journal 10(3):A119, 1996.

77. Shecterle LM, Kelly T, St.Cyr JA: Letter to the Editor, Safe and efficient method of inducing whole body hyperthermia. International Journal of Hyperthermia 12(4):569-571, 1996.

78. St.Cyr JA, Kelly T, Shecterle LM: Whole Body Extracorporeal Low Flow Hyperthermia in a Canine Model. J Extracorporeal Technology 28(3):140-146, 1996.

79. Shecterle LM, Myers R, Holton M, Kelly T, Zablow A, St.Cyr JA: Inducing whole body hyperthermia using a new extracorporeal device. Hyperthermic Oncology 1996, Vol. 2:275-277, 1996.

80. Zablow A, Dorian R, Myers R, Holton M, Kelly T, Shecterle L, St.Cyr J: Use of low flow extracorporeal whole body hyperthermia in the treatment of HIV disease, a feasibility study. Southern Med J 89(10):S150-51, 1996.

81. Shecterle LM, St.Cyr JA: The effects of radiant rewarming on pH (corrected vs uncorrected) in severely hypothermic canines. FASEB Journal 2:A526, 1997.

82. Shecterle LM, Kelly T, St.Cyr JA: Response, Letter to the Editor, “Safe and efficient method for inducing whole body hyperthermia.” International J Hyperthermia 13(3):339-340, 1997.

83. Shecterle LM, St.Cyr JA: A further comment on alternative HIV therapies. The

Scientist 11(9):10, 1997.

84. Zablow A, Shecterle L, Dorian R, Kelly T, Fletcher S, Forman M, Sanfilippo L, St.Cyr J: Extracorporeal whole body hyperthermia treatment in HIV patients, a feasibility study. Int J Hyperthermia 13(6):577-586, 1997.

85. Shecterle LM, St.Cyr JA: Hyperthermia in Medicine. Proc 4th Int Symposim on Biol Closed Elect Circuits, pp 286-289, 1997.

86. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia alters HIV kinetics, Results of a study. Alternative Therapies in Clinical Practice 4(5):162-164, 1997.

87. Shecterle LM, St.Cyr JA: Twelve month follow up in advanced HIV patients treated with whole body hyperthermia. Onkologie, J of Oncology 29(suppl 4a):12, 1997.

88. Shecterle LM, Wetherall NT, St.Cyr JA: Hyperthermia affects complement levels.

J Investigative Medicine 46(1):50A, 1997.

89. Shecterle LM, St.Cyr JA: Potential resolution of Zidovudine (AZT) anemia. J Investigative Medicine 46(1):65A, 1997.

90. Shecterle,LM, St.Cyr JA: Radiant rewarming for hypothermia: pilot canine study model. Journal Minnesota Academy of Science 62(1):12-16, 1997.

91. Shecterle LM, St.Cyr JA: US Patent, “Double Layer Prophylactic Incorporating

Pharmacological Fluid and Spiral Barrier Layer,” #5623945, 1997.

92. Myers R, Holton M, Kelly T, St.Cyr J, Dorian R, Cavanaugh L: The use of extracorporeal whole body hyperthermia in HIV/AIDS patients. Abstract, AMSECT meeting, 1998.

93. Shecterle LM, Clark L, St.Cyr JA: Metastatic prostate cancer treated with whole body hyperthermia: a case report. J Investigative Medicine 46(3):242A, 1998.

94. Zablow A, Shecterle LN, Kelly T, St.Cyr JA: Response to the letter to the Editor: Hyperthermia and AIDS: a Critical Review. Int J Hyperthermia 14(4):419, 1998.

95. St.Cyr J, Wetherall, N, Wernes L, Shecterle L, Blick G, Greiger P: HIV is heat

sensitive In Vitro. FASEB Journal 47(4):210A, 1999.

96. Rakow N, Nelson D, Boldt C, Pfenning K, McClay C, Waskiewicz J, Shecterle L, St.Cyr J: Chronic orthotopic aortic valve implantation model. Proceedings from the World Symposium on Heart Valve Disease. London, UK, page 188, 1999.

97. Shecterle L, Zablow A, Kelly T, St.Cyr J: Abnormal cervical histopathology reversed with whole body hyperthermia. FASEB Journal 47(4):208A, 1999.

98. Shecterle LM, St.Cyr JA: Response to a Letter to the Editor, “More on Hepatitis C,” The Scientists 13(11):12, 1999.

99. St.Cyr JA, Rakow NJ, Nelson DA, Pfenning KA, Boldt CW, McClay CB: Chronic model for aortic valve replacement. Medtronic’s, 10th Annual Science and Technology Conference, Abstract booklet, page 18, 1999.

100. Shecterle LM, Wetherall NT, St.Cyr JA: Effects on C3 and CH50 levels during and following extracorporeal whole body hyperthermia. J Extracorporeal Technology 31(4):191-4,1999.

101. Rakow N, Nelson D, Boldt C, Pfenning K, McClay C, Waskiewicz J, Shecterle L, St.Cyr J: Chronic orthotopic aortic valve implantation model. J Heart Valve Disease 9(6):822-8, 2000.

102. Shecterle LM, St.Cyr JA: Reversal of cervical dysplasia with hyperthermia. Letter to the Editor.

International J Hyperthermia 16(5):443-444, 2000.

103. Shecterle L, Rakow N, Waskiewicz J, Nelson D, Boldt C, St.Cyr J: Dobutamine stress evaluation of the Medtronic Advantage aortic prosthesis. FASEB Journal 14(4):A154. 2000.

104. Shecterle L, Holton M, Myers R, Zablow A, St.Cyr J: Delay in normalization of hematologic parameters following extracorporeal whole body hyperthermia. FASEB Journal 14(4):A87, 2000.

105. Vance R, Einzig S, Kreisler K, Shecterle L, St.Cyr J: D-Ribose maintains ejection fraction following aortic valve surgery. FASEB Journal 14(4):A419, 2000.

106. St.Cyr J, Johnson C: Composition for increasing energy in vivo. Patent #6159942, 2000.

107. Butler T, St.Cyr J: Use of ribose to prevent cramping and soreness in muscles. Patent #6159943, 2000.

108. Shecterle L, Grangaard R, Hudak J, Rakow N, Nelson D, St.Cyr J: Anesthetic management in sheep undergoing prosthetic valve implantation. FASEB Journal 15(5), Part 2:A1137, 2001.

109. Seifert JG, Frelich A, St.Cyr J: The toxicological effects of 14 days of ribose ingestion. FASEB Journal 15(5), Part 1:B392, 2001.

110. Illien S, Omran H, Mac Carter D, St.Cyr J: Ribose improves myocardial function in

congestive heart failure. FASEB Journal 15(5), Part 2:A1142, 2001.

111. Illien S, Omran H, Mac Carter D, St.Cyr J: Ribose improves myocardial function and quality of life in congestive heart failure patients. J Mol Cell Cardiol 33(6):A173, 2001.

112. Ericson D, Karnicki K, Shecterle LM, St.Cyr J, Rao G: Viacyte enhances functional parameters in stored platelets. Blood (suppl) 98(11):4057 (abst 104B), 2001.

113. Sawada S, St.Cyr J, Johnson CA: Method for determining viability of a myocardial

segment, #6339716, 2001.

114. St.Cyr J, Johnson C, Mac Carter D, Sawada S: Method for raising the hypoxic threshold, patent, #6218366, 2001.

115. Ericson D, Shecterle LM, St.Cyr J: D-Ribose maintains spermatocyte motility- a case report. FASEB journal 16(5), Part II:A781,2002.

116. Ericson D, St.Cyr J: Ehanced platelet function and extended eight day storage using new platelet preservative solution. Vox Sang 83 (Suppl 2): Abstr #023, page 9, 2002.

117. Ericson D, Karnicki K, Johnson C, St.Cyr J, Rao GHR: A new platelet preservative. Platelets 13(7): 431-32, 2002.

118. St.Cyr J, Johnson C, Hagerman S, Vasquez L, Butler T: Compositions for increasing athletic performance in mammals, Patent #6429198, 2002.

119. Rakow N, Nelson D, McClay C, Rose R, Leuer L, Boldt C, Shecterle L, St.Cyr J: Assessment of the Medtronic Advantage™ Aortic Valve Prosthesis. JHVD 11(6):851-856, 2002.

120. Wilson R, Johnson C, Mac Carter D, St.Cyr J: Ribose enhances the identification of hibernating myocardium. Heart Drug 3(1):61-2, 2003.

121. Shecterle L, Browdie D, St.Cyr J: Non-gluteraldehyde surgical adhesive. FASEB Journal 17(5):A937, 2003.

122. Pauly D, Johnson C, St.Cyr J: The role of ribose in cardiovascular disease. Med Hypoth 60(2):149-151, 2003.

123. Rakow N, Grangaard R, Allen N, Shecterle L, St.Cyr J: Aortic root replacement model in adult sheep. Medtronic’s Second Animal Model symposium, Page 11, 2003.

124. Fernholz KM, Seifert JG, Shecterle LM, St.Cyr JA: RiboGro enhances rooting development. J MN Acad Sci 67(1):29, 2003.

125. Omran H, Illien S, MacCarter D, St.Cyr J, Luderitz B: D-ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur J Heart Fail 5(5):615-9, 2003.

126. Butler T, St.Cyr J, Johnson C: Method for treating acute mountain sickness, Patent #6511964, 2003.

127. Ericson D, Lien S, Morari F, St.Cyr J, Adcock D: Ribose preserves aggregation in apheresis platelets. Blood 102(11):p63B, 2003.

128. Karnicki K, Johnson C, St.Cyr J, Ericson D, Rao G: Platelet storage solution improves the in vitro function of preserved platelet concentrates. Vox Sanguinis 85(4):262-266, 2003.

129. Percival S, Henken R, St.Cyr J, Johnson C, Butler T: Compositions for enhancing the immune response, Patent #6663859, 2003.

130. St.Cyr J, Johnson C: Compositions for increasing energy in vivo, Patent #6534480, 2003.

131. St.Cyr JA, Holton JM, Kelly TC, Shecterle LM: Dual lumen adjustable length cannulae for liquid perfusion or lavage, Patent #6692473, 2004.

132. Shecterle LM, Nelson D, Billstrom T, Passenheim J, Lieb C, Rakow N, St.Cyr J: Platelet gel/felt aids in hemostasis in total aortic root replacement in adult sheep. FASEB journal 18(5), Part II:A1302, 2004.

133. Falkner P, Millner H, Wahlberg P, Nelson D, Billstrom T, Shecterle L, Rakow N, Lieb C, St.Cyr J: Correlation of pre-operative and intra-operative echocardiographic assessment of the aortic valve annulus in adult sheep. FASEB journal 18(5), Part II:A1303, 2004.

134. Dodd S, Johnson C, Fernholz K, St.Cyr: The role of ribose in human skeletal muscle metabolism. Medical Hypotheses 62(5):819-824, 2004.

135. Omran H, Mac Carter D, St.Cyr J, Luderitz B: D-ribose aids congestive heart failure patients. Experimental and Clinical Cardiology 9(2):117-118, 2004.

136. Ericson D, St. Cyr J: Compositions for the storage of platelets, patent #6790603, 2004.

137. Falkner P, Millner H, Wahlberg P, Nelson D, Billstrom T, Shecterle L, Rakow N, Lieb C, St.Cyr J: Correlation of pre-operative and intra-operative echocardiographic assessments of the aortic valve annulus in adult sheep. 23^rd Annual Scientific and Technology conference, Medtronic, Inc. , Proceedings, p. 335, 2004.

138. Nelson D, Rakow N, Falkner P, Lieb C, Billstrom T, Grangaard R, Hammargren J, Alfson L, Shecterle L, St.Cyr J: Chronic orthotopic total aortic root replacement sheep model. 23^rd Annual Scientific and Technology Conference, Medtronic, Inc., Proceedings, p. 305, 2004.

139. Perkowski D, Wagner S, Marcus, A, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. 2^nd place prize, Proceedings from the Scripps Natural Supplement Conference, La Hoya, CA, Jan, 2005.

140. St.Cyr JA, Passwater R: Interview with Dr. Passwater. Interview Vitamin Connection: Ribose. Whole Foods Magazine, pp.45-47, 2005.

141. Perkowski D, Wagner S, Marcus A, Johnson C, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. Proceedings from New Era Cardiac Care 2005, p. 52, 2005.

142. Alfson L, Rakow N, Nelson D, Wahlberg P, Shecterle L, St.Cyr JA: Novel Chest Tube Circuitry. FASEB J (Part 1) 19(4):A636, 2005.

143. Perkowski D, Wagner S, Marcus A, St.Cyr J: Pre-surgical loading of oral D-Ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. FASEB J (Part 1) 19(4):A695, 2005.

144. Sharma R, Munger M, Litwin S, Vardeny O, MacCarter D, St.Cyr J: D-ribose improves Doppler TEI myocardial performance index and maximal exercise capacity in stage C heart failure. JMCC 38(5):853, 2005.

145. Vijay N, MacCarter D, Washam M, St.Cyr J: Ventilatory efficiency improves with D-ribose in congestive heart failure. JMCC 38(5):820, 2005.

146. Perkowski D, Wagner S, Marcus A, St.Cyr J: Ribose enhances ventricular function following off pump coronary artery bypass surgery. J Altern & Compl Med 11(4): 745, 2005.

147. Lemmon J, Nelson D, Rakow N, Barka N, Allen N, St.Cyr J: Transcatheter percutaneous pulmonary valve implantation in adult sheep: Model development. Proceedings from Medtronic’s 2^nd Animal Model Symposium, June, 2005.

148. Lemmon J, Nelson D, Rakow N, Barka N, Allen N, St.Cyr J: Transcatheter percutaneous pulmonary valve implantation in adult sheep: model development. Proceedings from the third biennial meeting of The Society for Heart Valve Disease, abstract # P134, p335, 2005.

149. Falkner P, Millner H, Nelson D, Rakow N, Shecterle LM, St.Cyr JA: Transthoracic echocradiographic technique for aortic valve annular determination in adult sheep undergoing prosthetic valve implantation. OJVR 9(2):83-94, 2005.

150. Vijay N, Mac Carter D, Washam M, Munger M, St.Cyr J: D-ribose improves ventilatory efficiency in congestive heart failure patients (NYHA classes II-IV). J Card Fail 11(6):abst 019,S95, 2005.

151. Johnson C, St.Cyr J: Letter to the Editor. Ribose preserves ventricular function following aortic valve surgery. Internet J of Thor and CV Surg, 7(2): Letter to the Editor, 2005.

152. Johnson C, Mac Carter D, St.Cyr J: Letter to the Editor. Recovery of depressed myocardial energy levels. Internet J of C-V Res, 2(2): Letter to the Editor, 2005.

153. Johnson C, St.Cyr J: Letter to the Editor. Ribose preserves ventricular function following aortic valve surgery. Internet J of C-V Res, 2(2): Letter to the Editor, 2005.

154. Alfson L, Rakow N, Nelson D, Shecterle L, St.Cyr J: Chest tube drainage circuitry in mammals. Vet Surg 34(5):537, 2005.

155. Shecterle LM, St.Cyr JA: It’s Payback Time, Letter to the editor, Phi Kappa Phi Forum, Winter/Spring, 86(1):40, 2005-06.

156. Shecterle LM, St.Cyr JA: A novel therapeutic approach to advanced lung cancer. The Int J Oncol 3(1), 2005.

157. St.Cyr JA: Corvalen M-Your natural supplement for restoring energy. NFA Fibromyalgia Online, 5(16): 2005.

158. St.Cyr J: Condition Specific Nutrition: CORvalen M. Total Health, 27(5):27, 2005.

159. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. Proceedings of the Am Thor Soc, 3 (Abstract issue):A651, 2006.

160. Vijay N, Mac Carter D, Washam M, St.Cyr J: D-ribose benefits low level exercise in advanced class CHF patients. J Card Fail 12(6), Suppl: #401,S122, 2006.

161. Shecterle LM, Vertress, R, Zwischenberger J, St.Cyr JA: Hyperthermia aids patients with advanced lung cancer, editorial. Society for Thermal Medicine, 2006 Annual Meeting Program and Abstract Proceedings, p. 56, 2006.

162. Rakow N, Nelson D, Falkner P, Wahlberg P, Grangaard R, Capps M, Billstrom T, Shecterle LM, St. Cyr JA: Orthotopic total aortic root replacement model in adult sheep. J Invest Surg 20(1):55-59, 2007.

163. Teitelbaum JE, Johnson C, St.Cyr JA: The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. J Alt & Comp Med 12(9):857-862, 2006.

164. Griffiths JC, Borzelleca JL, St.Cyr J: Sub-chronic (13 week) oral toxicity study with D-ribose in Wistar rats. J Food and Chem Tox 45(1):144-152, 2007.

165. Griffiths JC, Borzelleca JL, St.Cyr J: Lack of oral embryotoxicity/teratogenicity with D-ribose in Wistar rats. J Food and Chem Tox 45(3):388-395, 2007.

166. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose improves cardiac indices in patients undergoing “off” pump coronary arterial revascularization. J Surg Res 137(2):295, 2007.

167. Teitelbaum J, St.Cyr J, Johnson C: Effective treatment of chronic fatigue syndrome and fibromyalgia with D-ribose. Syllabus, International Association for Chronic Fatigue Syndrome (IACFS/ME) meeting, fatigue section, 2007.

168. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, St.Cyr J, Rakow N, Barka N, Billstrom T: In-vivo motion of mitral valve annuloplasty devices. Proceedings from Medtronic, Inc.’s 25^th Annual S&T Conference, 2006.

169. Griffiths J, St.Cyr J: D-ribose has non-significant toxicity in both short and long term supplementation. The Toxicologist 96(S-1):p. 299, 2007.

170. Borel M, Calmon E, Bezivin C, Pletsch S, St.CyrJ: D-ribose enhances basal and mitochrondrial respiratory rates in human dermal fibroblasts. FASEB journal, 21(6):A835, 2007.

171. Perkowski D, Wagner S, St.Cyr J: D-ribose benefits “off” pump coronary artery bypass revascularization. J Card Surg 22(4):370-371, 2007.

172. Rakow N, Barka N, Nelson D, Allen N, Gringaard R, Falkner P, Wahlberg P, Lemmon J, Phillips L, Billstrom T, Hill A, Shecterle L, St.Cyr J: Right ventricular outflow tract reconstruction model in adult sheep for placement of the Melody transcatheter pulmonary valve. J Invest Surg 20(3):187-193, 2007.

173. Redmond J, Christiansen D, Bergin C, Ryan T, Rakow N, Barka N, St.Cyr J, Grossi E: In vivo motion of mitral valve annuloplasty devices. The Society for Heart Valve Disease, 4^th Biennial Meeting, June 2007, abstract #13.

174. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, Rakow N, Barka N, Billstrom T, Shecterle L, St.Cyr J, Grossi E. Differences in mitral valve annular function under full and partial ring annuloplasty. J Heart Disease 5(1):abst #615, p 154m 2007, 13^th World Congress on Heart Disease.

175. Perkowski D, Wagner S, Marcus A, St.Cyr J: D-ribose and “off” pump coronary artery bypass revascularization aids in cardiac indices following acute myocardial infarction. J Heart Disease 5(1):abst #366, p 92, 2007, 13^th World Congress on Heart Disease.

176. Lamberts RR, Caldenhoven E, Lansink M, Witte G, St.Cyr JA, Stienen GJM: D-ribose/folic acid aids right ventricular diastolic function in induced pulmonary hypertension. J Heart Disease 5(1):abst #255, p 64, 2007, 13^th World Congress on Heart Disease.

177. Lamberts RR, Caldenhoven E, Lansink M, Witte G, Vaessen RJ, St.Cyr JA, Stienen GJM. Preservation of diastolic function in monocrotaline-induced right ventricular hypertrophy. Am J Physiol: Heart Circ Physiol 102(1):19-27, 2007.

178. MacCarter D, Shecterle LM, St.Cyr JA. D-Ribose benefits COPD. Internet J Pulm Med 7(2), 2007.

179. MacCarter D, Miller F, Sierminski H, St.Cyr J, Vijay N. VV optimization improves breathing and oxygen uptake efficiency. J Card Fail 13(6): page S188, 2007.

180. MacCarter D, Vijay N, Sierminski H, Anderson S, St.Cyr J. Muti-Parameter Index (MPI), Sub-Maximal heart and lung based risk scores for heart disease. J Card Fail 13(6):page S188, 2007.

181. Redmond J, Christiansen D, Bergin C, Leur L, Ryan T, Rakow N, Barka N, Billstrom T, Shecterle L, St.Cyr J. Differences in mitral valve annular function under full and partial ring annuloplasty. Recent Advances in Cardiovascualr Disease. Proceedings of the 13^th World Congress on Heart Failure. Medimond Publishing, Bologna, Italy, pp 457-460 (H728C0309), 2008.

182. Redmond J, Christiansen D, Bergin C, Leuer L, Ryan T, Rakow N, Barka N, Billstrom T, St.Cyr JA, Shecterle LM, Grossi E. In-vivo motion of mitral valve annuloplasty devices. JHVD 17(1):110-118, 2008.

183. St.Cyr JA. Energy for the heart: D-ribose supplementation can boost and restore myocardial metabolism. Advances in Healthy Aging 3(4):47-48, 2007.

184. Vijay N, MacCarter D, Shecterle LM, St.Cyr JA. Letter to the Editor. D-ribose benefits heart failure patients. J Med Food 11(1):199-200, 2008.

185. Fullerton DA, St.Cyr JA. Letter to the Editor. Mixed venous oxygen saturation in the diagnosis of cardiac tamponade. J Card Surg 23(2):180-181, 2008.

186. Perkowski D, Wagner S, St.Cyr J. D-ribose and “off” pump coronary artery bypass revascularization aids cardiac indices following acute myocardial infarction. Proceedings from the 11^th Annual New Era Cardiac Care: Innovation and Technology. San Diego, 2008.

187. Fenstad ER, Gazal O, Shecterle LM, St.Cyr JA, Seifert JG. Dose effects of D-ribose on glucose and purine metabolites. The Internet Journal of Nutrition and Wellness 5(1), 2008.

188. Sperduto CM, St.Cyr J, Papermaster Bender G, Sperduto P. A prospective randomized clinical trial of ribose in patients with advanced cancer: An analysis of oxygen saturation and fatigue. Oncology 22(4), supplement 1:p21, 2008.

189. Perkowski DJ, Wagner SL, St.Cyr JA. D-ribose improves cardiac index in patients undergoing “off” pump coronary artery revascularization. JMCC 44(6, Supplement )1:S5-6, 2008.

190. Seifert J, Frelich A, Shecterle L, St.Cyr J. Assessment of hematological and biochemical parameters with extended D-ribose ingestion. J Int Soc Sports Nutr 5(1):13, 2008.

191. Freeman ML, Mertens-Talcott S, St.Cyr J, Percival SS. Ribose enhances retinoic acid-induced differentiation of HL-60 cells. Nutr Res 28(11):775-782, 2008.

192. Herrick J, St.Cyr J. Ribose in the Heart. J Dietary Supplements 5(2):213-217, 2008.

193. Shecterle L, Kasubick R, St.Cyr J. D-ribose benefits Restless Legs Syndrome. J Alt & Comp Med 14(9):1156-66, 2008.

194. St.Cyr JA, Schneider JR. Letter to the Editor. A Sugar that benefits Failing Hearts. Internat J Card 131(3):398, 2009.

195. MacCarter D, Flannigan R, Washam M, Shecterle LM, St.Cyr J. D-ribose improves fatigue in adults. J Alt & Comp Med 15(7):812, 2009.

196. Sawada SG, Lewis S, Kovacs R, Khouri S, Gradus-Pizlo I, St.Cyr J, Feigenbaum H. Evaluation of the anti-ischmic effects of D-ribose during dobutamine stress echocardiography: a pilot study. Cardiovasc Ultrasound 7(5):7120-7, 2009.

197. Herrick J, Shecterle LM, St.Cyr JA. D-ribose–an additive with caffeine. Medical Hypotheses 72(5):499-500, 2009.

198. Butler T, St.Cyr J, Johnson C. Composition methods for improving cardiovascular function. Patent, #7553817, 2009.

199. Wagner S, Herrick J, Shecterle LM, st.Cyr JA. D-ribose, A metabolic substrate for congestive heart failure. Prog Cardiovasc Nurs 24:59-60, 2009.

200. Seifert JG, Subudhi AW, Fu MX, Riska KL, John JL, Shecterle LM, St.Cyr JA. The role of ribose on oxidative stress during hypoxic stress: A pilot study. J Med Food 12(3):690-693, 2009.

201. MacCarter D, Vijay N, Washam M, Shecterle LM, Sierminski H, St.Cyr JA: Letter to the Editor. D-ribose Aids Advanced Ischemic Heart Failure Patients. Internat J Card, 137(1):79-80, 2009.

202. Kopcak M, Leet C, Rakow N, Barka N, St.Cyr J. Dual arterial cannulation for aortic surgical procedures in adult sheep. 28^th Annual Science and Technology Conference, Medtronic Inc., 2009.

Shecterle LM, St.Cyr JA. Dermal benefits of topical D-ribose. Clinical, Cosmetic and Investigated

Dermatology, 2:151-152, 2009.

Wagner S, Shecterle L, St.Cyr J. A simple 5-carbon sugar which has potential as a metabolic substrate for

congestive heart failure. Proceedings from the 8^th International Congress on Coronary Artery Disease:

From prevention to intervention. Abstract #1152, 2009.

Perkowski D, Wagner S, Shecterle L, St.Cyr J. Off-pump coronary artery bypass with a metabolically

directed protocol with D-ribose. Proceedings from the 8^th International Congress on Coronary Artery

Disease: From prevention to intervention. Abstract #1153, 2009.

206. Flanigan R, MacCarter D, Shecterle L, St.Cyr J. D-ribose aids fatigue in aging adults. Letter to the Editor.

J Alt & Comp Med;16(5):529-530, 2010.

207. Brookman R, St.Cyr J. Metabolic supplementation with enhanced external counterpulsation improves

myocardial function in acquired cardiomyopathy: A case report. J Alt & Comp Med 16(3):323-325, 2010.

208. Wagner SL, Schneider JR, St.Cyr JA, Perkowski DJ. A metabolic approach for “off pump” coronary artery

bypass. Proceedings from the American College of Surgeons, Southern California Chapter meeting, 2010.

209. St.Cyr J, Ericson D, Johnson C. Rejuvenation of stored blood, Patent USP7687468, 2010.

210. Shecterle LM, Terry KR, St.Cyr JA. The patented uses of D-ribose in cardiovascular diseases. Recent Pat

Cardiovasc Drug Dis. 5(2):138-42, 2010.

211. Shecterle L, St.Cyr J. Letter to the Editor. Nutraceuticals aid dermal fibroblasts. The Internet Journal

of Nutrition and Wellness 9(2), 2010.

212. Shecterle LM, St.Cyr JA. Case Report. Visual success following complications from multiple retinal

detachments. The Internet Journal of Ophthalmology and Visual Science 7(2), 2010.

Shecterle LM, St.Cyr JA. High strength biocompatible hemostatic tissue adhesive. Proceedings from the

North Atlantic Treaty Organization (NATO) symposium, “Use of advanced technologies and new procedures in medical field operations,” Essen, Germany; p25, 2010.

214. Kocheril A, St.Cyr JA, MacCarter D. The importance of cardiopulmonary exercise testing. Eur Heart J,

E-letter online, May 14, 2010.

215. Kopcak M, Barka N, Rakow N, Leet C, Shecterle L, St.Cyr J. Dual arterial cannulation for aortic surgical

procedures in adult sheep. Eur Surg Res 45(1): 9-12, 2010.

216. Seifert J, Shecterle L, St.Cyr J. Supplements for exercise. Commentary. J Dietary Supplements 7(4):414-416, 2010.

217. MacCarter D, Kocheril A, Flanigan R, St.Cyr J. Assessing diastolic dysfunction. Letter to the Editor. Internat J Card 145(3):610, 2010.

218. Barka N, Kopcak M, Kelly T, Schendel M, Hill A, Grangaard R, Allen N, Shecterle L, St.Cyr J. Pressure load sensing assessments of the right ventricular outflow tract and main pulmonary artery. Surgical Technique. J Invest Surg 24(2):77-80, 2010.

219. Shecterle LM, St.Cyr JA. Metabolic energy changes during exercise in equines. Veterinary Medicine: Research and Report 2010(1):1-2, 2010.

220. Shecterle LM, Wagner S, St.Cyr JA. A sugar for congestive heart failure patients. Ther Adv Cardiovasc Dis 5(2):95-97, 2011.

221. Perkowski D, Wagner S, Schneider JR, St.Cyr JA. A targeted metabolic protocol with D-ribose for off pump coronary artery bypass procedures: A retrospective analysis. Ther Adv Cardiovasc Dis 5(4):185-192, 2011.

222. Foker J, Berry J, Harvey B, Befera N, Tveter K, St.Cyr J, Bianco R. Heart failure is initiated by and progresses because of normal responses of energy metabolism to stress. Circ Res , 2011.

223. Rakow N, Barka N, Gerhart R, Rothstein P, Green M, Schu C, Grassl E, St.Cyr JA, Kopcak MW, Jr. Chronic aortic root pressure-loading assessment model. J Invest Surg 25(2):137, 2012.

224. Shecterle LM, St.Cyr JA. Chapter 11; Myocardial Ischemia: Alterations in myocardial cellular energy and diastolic function, a potential role for D-ribose. In: Novel Strategies in Ischemia Heart Disease. Lakshmanadoss U(Ed). InTech, Croatia. 219-228, 2012.

225. Addis P, Shecterle LM, St.Cyr JA. Cellular protection during oxidative stress: a potential role for D-ribose and antioxidants. Journal of Dietary Supplements 9(3):178-182, 2012.

226. Holsworth R, Shecterle L, St.Cyr J, Sloop G. Letter to the Editor. Importance of monitoring blood viscosity during cardiopulmonary bypass. Perfusion 28(1):91-2, 2013.

227. Seifert JG, Frost J, ST.Cyr JA. Recovery benefits of a heat and moisture exchange mask when performing sprint exercise in cold temperature environments. Aviation, Space and Environmental Medicine. , 2013.

228. Seifert JG, McNair M, DeClercq P, St.Cyr JA. A heat and moisture mask attenuates cardiovascular stress during cold air exposure. Ther Adv Cardiovasc Dis 7(3):123-129, 2013.

229. Holsworth R, Cho Y, Weldman J, Sloop G, St.Cyr, J. Cardiovascular benefits of phlebotomy: Relationship to changes in hemorheological variables. Perfusion, 2013.

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com